Entity
  • Limula

    Created in 2020
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups
  • Social networks

    5,254
  • Activities

  • Technologies

  • Entity types

  • Location

    Rte de la Corniche 5, 1066 Epalinges, Switzerland

    Epalinges

    Switzerland

  • Employees

    Scale: 2-10

    Estimated: 24

  • Engaged corporates

    2
    1 2
  • Added in Motherbase

    1 year, 8 months ago
Description
  • Value proposition

    Cell & Gene Therapy: Automated. Scalable. Accessible

    Limula provides an innovative solution for the production of the most personalised cancer treatments on demand and at scale. Our product is a unique proprietary platform can perform multiple steps of cell therapy manufacturing in a single device, using end-to-end automation and integrated process analytics.

    Bioproduction, Immunooncology, Cell therapy, Biotechnolgoy, Manufacturing, and CAR-T

Corporate interactions BETA
Corporate TypeTweets Articles
MassChallenge
MassChallenge
Startup accelerator & VC, Venture Capital and Private Equity Principals
MassChallenge
Startup accelerator & VC, Venture Capital and Private Equity Principals
Other

31 May 2024


Innovaud
Innovaud
International Trade and Development
Innovaud
International Trade and Development
Other

6 Oct 2020

31 May 2024



Similar entities
Loading...
Loading...
Social network dynamics